Free Trial

Citius Oncology (CTOR) Earnings Date, Estimates & Call Transcripts

Citius Oncology logo
$0.90 +0.00 (+0.45%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Citius Oncology Earnings Summary

Citius Oncology released Q2 2025 earnings on May 14, 2025, reporting an EPS of -$0.11, which missed the consensus estimate of -$0.09 by $0.02. Citius Oncology currently has a trailing EPS of $0.00

Q2 2025 Earnings Resources

Latest Q2 2025
Earnings Date
May. 14Estimated
Consensus EPS
(May. 14)
-$0.09
Actual EPS
(May. 14)
-$0.11 Missed By -$0.02
Get Citius Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Citius Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CTOR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Citius Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2025Q2 2025-$0.09-$0.11 -$0.02-$0.11$5.74M-
2/14/2025---$0.09 -$0.09-$0.09--


This page (NASDAQ:CTOR) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners